Joanne L. Blum
- Oncology top 0.5%
- Cancer Research top 0.5%
- Pulmonary and Respiratory Medicine top 1%
- Molecular Biology top 10%
- Genetics top 2%
- Co-authors
- Joyce O’ShaughnessyAnthony GonçalvèsHenri RochéJennifer K. LittonHope S. RugoLida A. MinaSara A. HurvitzJohannes Ettl
- Topics
- Cancer Treatment and Pharmacology (46 papers)Advanced Breast Cancer Therapies (40 papers)Breast Cancer Treatment Studies (28 papers)
- Cited by
- OncologyCancer ResearchDermatology
- Partner nations
- United StatesSpainFrance
In The Last Decade
Joanne L. Blum
92 papers receiving 5.5k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Oncology 4.7k
- Cancer Research 1.9k
- Pulmonary and Respiratory Medicine 1.5k
- Molecular Biology 1.3k
- Genetics 831
Countries citing papers authored by Joanne L. Blum
This map shows the geographic impact of Joanne L. Blum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanne L. Blum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanne L. Blum more than expected).
Fields of papers citing papers by Joanne L. Blum
This network shows the impact of papers produced by Joanne L. Blum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanne L. Blum. The network helps show where Joanne L. Blum may publish in the future.
Co-authorship network of co-authors of Joanne L. Blum
This figure shows the co-authorship network connecting the top 25 collaborators of Joanne L. Blum. A scholar is included among the top collaborators of Joanne L. Blum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanne L. Blum. Joanne L. Blum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 8 | |
| 4 | 3 | |
| 5 | 2 | |
| 6 | 5 | |
| 7 | 1 | |
| 8 | Talazoparib versus chemotherapy in patients with germline BRCA1/2-mutated HER2-negative advanced breast cancer: final overall survival results from the EMBRACA trialbreakdown → | 252 |
| 9 | Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutationbreakdown → | 1401 |
| 10 | 37 | |
| 11 | 31 | |
| 12 | 50 | |
| 13 | 37 | |
| 14 | 400 | |
| 15 | 20 | |
| 16 | 136 | |
| 17 | 12 | |
| 18 | 258 | |
| 19 | 30 | |
| 20 | 84 |
About Joanne L. Blum
Joanne L. Blum is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 93 papers that have together received 5.6k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (46 papers), Advanced Breast Cancer Therapies (40 papers) and Breast Cancer Treatment Studies (28 papers). The work is most often cited by research in Oncology (4.7k citations), Cancer Research (1.9k citations) and Dermatology (474 citations). Joanne L. Blum has collaborated with scholars based in United States, Spain and France. Frequent co-authors include Joyce O’Shaughnessy, Anthony Gonçalvès, Henri Roché, Jennifer K. Litton, Hope S. Rugo, Lida A. Mina, Sara A. Hurvitz, Johannes Ettl, Ruben G.W. Quek and W. Eiermann. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.